Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-02-05T09:26:29+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

Dimerix Recommended as Stock To Watch

Investment Manager Tony Locantro from Alto Capital has recommended Dimerix stock as a good investment on his Bulls, Bears and Brokers [...]

ASX: Further US Patent Application Allowed For DMX-200

Dimerix is pleased to announce the receipt of a Notice of Allowance from the US Patent and Trade Mark Office (USPTO) [...]

2018 Gold Coast Investment Showcase Presentation

CEO Kathy Harrison Presents at the 2018 Gold Coast Investment Showcase

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation